+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Avanir Pharmaceuticals Inc  - logo

Avanir Pharmaceuticals focuses on the research, development and commercialization of novel medical and pharmaceutical treatments for people with central nervous system disorders. It primarily offers NUEDEXTA, a dual N-methyl-D-aspartate receptor antagonist and sigma-1 agonist for the treatment of pseudobulbar affect; and Docosanol 10% cream, an over-the-counter product for the treatment of cold sores. Avanir Pharmaceuticals was founded in 1988 and is headquartered in Aliso Viejo, California.

From
From
From
From
From
From
Major Depressive Disorder - Pipeline Insight, 2021 - Product Thumbnail Image

Major Depressive Disorder - Pipeline Insight, 2021

  • Drug Pipelines
  • May 2021
  • 120 pages
From
Neuropathic Pain - Pipeline Review, H2 2019 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 838 pages
From
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 pages
From
From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • February 2017
  • 91 pages
From
From
Depression - Pipeline Review, H2 2020 - Product Thumbnail Image

Depression - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 737 pages
From
Serotonin Transporter Inhibitor - Pipeline Insight, 2020 - Product Thumbnail Image

Serotonin Transporter Inhibitor - Pipeline Insight, 2020

  • Drug Pipelines
  • July 2020
  • 60 pages
From
Sigma Receptor Agonist - Pipeline Insight, 2020 - Product Thumbnail Image

Sigma Receptor Agonist - Pipeline Insight, 2020

  • Drug Pipelines
  • July 2020
  • 60 pages
From
From
Loading Indicator
adroll